Polymorphisms and Mutations of ACE2 and TMPRSS2 genes are Associated with COVID-19: a systematic review

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2022 Feb 23

PMID 35193695

Authors

Jingwei Li

Yali Wang

Yong Liu

Ziqu Zhang

YuYun Zhai

Yan Dai

Zijian Wu

Xiang Nie

Lunfei Du

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the effect of polymorphisms and mutations in angiotensin-converting enzyme 2 (ACE2) and Type 2 transmembrane serine proteases (TMPRSS2) genes on susceptibility to corona virus disease 2019 (COVID-19) and patient prognosis.

Introduction: From December 2019 to the current time, an outbreak of epidemic of COVID-19, characterized by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has occurred around the world. It is now clear that SARS-CoV-2 binds to human ACE2 receptors, with expression of these receptors correlated with the rate of SARS-CoV-2 infection and mortality. Polymorphisms in individual patient factors, such as ACE2 and TMPRSS2 genes have been linked with an increase in negative outcomes, although evidence to affirm remains debatable.

Methods: Here, we performed a systematic review, based on guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) criteria, with the aim of assessing whether polymorphisms in ACE2 and TMPRSS2 genes affect the COVID-19 condition. We extensively searched PubMed, MEDLINE, Embase, the Cochrane Library, and Web of Science databases, for relevant articles and reports published in English between December 2019 and December 2021.

Results: A total of 495 full-text articles were downloaded, of which 185 were excluded after preliminary examination as they were duplicates. Finally, 310 articles were evaluated, by reading their titles and abstracts, and 208 of them eliminated based on our selection criteria. Finally, 33 articles met our inclusion criteria and were included in the final assessment. Genetic data from 33,923 patients with COVID-19 drawn from the general population and deriving from over 160 regions and 50 countries, as well as approximately 560,000 samples from global-public genetic databases, were included in our analysis. Ultimately, we identified 10 SNPs and 21 mutations in the ACE2 gene, along with 13 SNPs and 12 variants in the TMPRSS2 gene, which may be associated with COVID-19.

Conclusions: ACE2 and TMPRSS2 play vital roles in the onset, development, and prognosis of SARS-CoV-2 infection, and have both been strongly associated with vulnerability, intensity, and the clinical result of COVID-19. Overall, these genetic factors may have potential for future development of personalized drugs and vaccines against COVID-19.

Trial Registration: CRD42021239400 in PROSPERO 2021.

Citing Articles

Genetics of Long COVID: Exploring the Molecular Drivers of Persistent Pulmonary Vascular Disease Symptoms.

Ayyoub S, Dhillon N, Tura-Ceide O Infect Dis Rep. 2025; 17(1).

PMID: 39997467 PMC: 11855385. DOI: 10.3390/idr17010015.

Risk impact of SARS-CoV-2 coronavirus and spike protein on cardiac tissue: a comprehensive review.

Sery O, Dziedzinska R Physiol Res. 2025; 73(S3):S655-S669.

PMID: 39808169 PMC: 11827061. DOI: 10.33549/physiolres.935476.

Differential Inflammatory and Immune Response to Viral Infection in the Upper-Airway and Peripheral Blood of Mild COVID-19 Cases.

Gajate-Arenas M, Garcia-Perez O, Dominguez-de-Barros A, Sirvent-Blanco C, Dorta-Guerra R, Garcia-Ramos A J Pers Med. 2024; 14(11).

PMID: 39590591 PMC: 11595938. DOI: 10.3390/jpm14111099.

Association of ACE2 and TMPRSS2 genes variants with disease severity and most important biomarkers in COVID-19 patients in Bosnia and Herzegovina.

Meseldzic N, Prnjavorac B, Dujic T, Malenica M, Glamoclija U, Prnjavorac L Croat Med J. 2024; 65(3):220-231.

PMID: 38868968 PMC: 11157263.

The weekly P25 of the age of the influenza-like illness shows a higher correlation with COVID-19 mortality than rapid tests and could predict the evolution of COVID-19 pandemics in sentinel surveillance, Piura, Perú, 2021.

Ocana Gutierrez V, Gonzalez Ramirez R, Ocana Aguilar V, Ocana Aguilar N, Holguin Mauricci C PLoS One. 2024; 19(3):e0295309.

PMID: 38452053 PMC: 10919873. DOI: 10.1371/journal.pone.0295309.

References

Cafiero C, Rosapepe F, Palmirotta R, Re A, Ottaiano M, Benincasa G . Angiotensin System Polymorphisms' in SARS-CoV-2 Positive Patients: Assessment Between Symptomatic and Asymptomatic Patients: A Pilot Study. Pharmgenomics Pers Med. 2021; 14:621-629. PMC: 8166347. DOI: 10.2147/PGPM.S303666. View

Mir M, Mir R, Alghamdi M, Alsayed B, Wani J, Alharthi M . Strong Association of Angiotensin Converting Enzyme-2 Gene Insertion/Deletion Polymorphism with Susceptibility to SARS-CoV-2, Hypertension, Coronary Artery Disease and COVID-19 Disease Mortality. J Pers Med. 2021; 11(11). PMC: 8621157. DOI: 10.3390/jpm11111098. View

Qi J, Zhou Y, Hua J, Zhang L, Bian J, Liu B . The scRNA-seq Expression Profiling of the Receptor ACE2 and the Cellular Protease TMPRSS2 Reveals Human Organs Susceptible to SARS-CoV-2 Infection. Int J Environ Res Public Health. 2021; 18(1). PMC: 7794913. DOI: 10.3390/ijerph18010284. View

Guo X, Chen Z, Xia Y, Lin W, Li H . Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2). J Transl Med. 2020; 18(1):321. PMC: 7443814. DOI: 10.1186/s12967-020-02486-7. View

Liu H, Xin J, Cai S, Jiang X . Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor. Elife. 2021; 10. PMC: 8282334. DOI: 10.7554/eLife.64188. View

Hamet P, Pausova Z, Attaoua R, Hishmih C, Haloui M, Shin J . SARS-CoV-2 Receptor ACE2 Gene Is Associated with Hypertension and Severity of COVID 19: Interaction with Sex, Obesity, and Smoking. Am J Hypertens. 2021; 34(4):367-376. PMC: 7799248. DOI: 10.1093/ajh/hpaa223. View

Jeon S, Blazyte A, Yoon C, Ryu H, Jeon Y, Bhak Y . Regional TMPRSS2 V197M Allele Frequencies Are Correlated with COVID-19 Case Fatality Rates. Mol Cells. 2021; 44(9):680-687. PMC: 8490206. DOI: 10.14348/molcells.2021.2249. View

Zarubin A, Stepanov V, Markov A, Kolesnikov N, Marusin A, Khitrinskaya I . Structural Variability, Expression Profile, and Pharmacogenetic Properties of TMPRSS2 Gene as a Potential Target for COVID-19 Therapy. Genes (Basel). 2020; 12(1). PMC: 7823984. DOI: 10.3390/genes12010019. View

Schonfelder K, Breuckmann K, Elsner C, Dittmer U, Fistera D, Herbstreit F . Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study. Front Genet. 2021; 12:667231. PMC: 8097083. DOI: 10.3389/fgene.2021.667231. View

10.

Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

11.

Curtis D . Variants in ACE2 and TMPRSS2 Genes Are Not Major Determinants of COVID-19 Severity in UK Biobank Subjects. Hum Hered. 2021; 85(2):66-68. PMC: 8089417. DOI: 10.1159/000515200. View

12.

Khan S, Zaidi S . Review of evidence on using ACEi and ARBs in patients with hypertension and COVID-19. Drugs Ther Perspect. 2020; 36(8):347-350. PMC: 7281700. DOI: 10.1007/s40267-020-00750-w. View

13.

Xue X, Shi J, Xu H, Qin Y, Yang Z, Feng S . Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans. Sci Rep. 2021; 11(1):3187. PMC: 7862608. DOI: 10.1038/s41598-021-82938-2. View

14.

Strafella C, Caputo V, Termine A, Barati S, Gambardella S, Borgiani P . Analysis of Genetic Variability among Populations Highlights a Possible Link with COVID-19-Related Neurological Complications. Genes (Basel). 2020; 11(7). PMC: 7397291. DOI: 10.3390/genes11070741. View

15.

Latini A, Agolini E, Novelli A, Borgiani P, Giannini R, Gravina P . COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells. Genes (Basel). 2020; 11(9). PMC: 7565048. DOI: 10.3390/genes11091010. View

16.

Smatti M, Al-Sarraj Y, Albagha O, Yassine H . Host Genetic Variants Potentially Associated With SARS-CoV-2: A Multi-Population Analysis. Front Genet. 2020; 11:578523. PMC: 7567011. DOI: 10.3389/fgene.2020.578523. View

17.

Kuba K, Imai Y, Ohto-Nakanishi T, Penninger J . Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010; 128(1):119-28. PMC: 7112678. DOI: 10.1016/j.pharmthera.2010.06.003. View

18.

Nelson C, Sama I, Codd V, Webb T, Ye S, Lang C . Genetic Associations With Plasma Angiotensin Converting Enzyme 2 Concentration: Potential Relevance to COVID-19 Risk. Circulation. 2020; 142(11):1117-1119. DOI: 10.1161/CIRCULATIONAHA.120.049007. View

19.

Suryamohan K, Diwanji D, Stawiski E, Gupta R, Miersch S, Liu J . Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Commun Biol. 2021; 4(1):475. PMC: 8041869. DOI: 10.1038/s42003-021-02030-3. View

20.

Srivastava A, Pandey R, Singh P, Kumar P, Rasalkar A, Tamang R . Most frequent South Asian haplotypes of ACE2 share identity by descent with East Eurasian populations. PLoS One. 2020; 15(9):e0238255. PMC: 7494073. DOI: 10.1371/journal.pone.0238255. View